Equitable EQH
- Market cap
- $14.4B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.4×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $10.6B
- −22% on a year ago
- Net margin
- −8.7%
- Free cash flow yield
- n/m
- not a meaningful number
Equitable trades at 1.4× sales. Its trailing earnings are negative, so it has no PE. Revenue was $10.6B over the last twelve months, down 22% on a year earlier with a −9% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.6B+21% | $2.1B+16% | $2.2B−5% | $3.5B+48% | $3.1B−15% | $3.6B+71% | $4.6B+105% | $2.4B−33% | $1.4B−53% | $3.3B−9% | $4.2B−8% | $1.7B−30% | |
| Interest expense | $55M+8% | $57M+8% | $57M−7% | $62M+13% | $55M+0% | $52M−9% | $55M−4% | $61M−2% | $61M+11% | $47M−10% | $62M+13% | $56M−8% |
| Pre-tax income | $1.5B+76% | −$815M | $219M | $681M+26% | −$11M | $1.2B | $174M−21% | −$363M | −$1.3B+12155% | $344M−71% | $887M+410% | −$493M+36% |
| $336M+90% | −$227M | $24M | $116M | −$39M | $179M | $24M+0% | −$80M | −$133M+241% | $33M−82% | $156M+550% | −$140M+75% | |
| Net income | $1B+76% | −$697M | $92M−48% | $428M−44% | −$132M | $892M | $63M−32% | −$349M | −$1.3B+892% | $215M−76% | $621M+886% | −$453M+30% |
| $2.97+93% | −$2.14 | $0.23−49% | $1.23−40% | −$0.46 | $2.74 | $0.16−30% | −$1.21 | −$4.47+872% | $0.71−74% | $2.14+1238% | −$1.68+39% | |
| 348M−8% | 337.3M−9% | 332.7M−9% | 327.3M−8% | 318.2M−9% | 316.2M−6% | 311.9M−6% | 303.2M−7% | 296.2M−7% | 285.3M−10% | 283.8M−9% | 278.3M−8% |
Income tax: Q4 FY19: the year less its other three quarters as the newest filings print them.
Net income: Q4 FY19: the year less its other three quarters as the newest filings print them.
EPS, diluted: 10 periods, Q1 FY17 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY17 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY18: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. 3 periods, Q4 FY19 to Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Brokers nearest Equitable's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| EQHEquitable | $14.4B | n/m | 11.1× | n/m | 1.4× | −22% | −8.7% |
| ERIEErie Indemnity | $13.3B | 23.0× | 31.6× | n/m | 3.2× | +4% | 14.0% |
| RYANRyan Specialty | $11.2B | 60.7× | 92.3× | n/m | 3.5× | +14% | 3.1% |
| BROBrown & Brown | $24.4B | 21.8× | 29.1× | 15.7× | 3.6× | +34% | 17.7% |
| WTWWillis Towers Watson Public | $30.2B | 19.9× | 26.0× | 15.5× | 3.0× | +3% | 15.5% |
| ACTEnact | $6.6B | 10.1× | 7.8× | n/m | 5.3× | +2% | 54.5% |
| HGTYHagerty | $5.4B | 260× | 50.9× | n/m | 3.7× | +8% | 1.8% |
| CRVLCorvel | $4.2B | 37.3× | 38.1× | n/m | 4.3× | +7% | 11.7% |
| NPNeptune Insurance | $3.9B | 91.7× | 126× | n/m | 19.9× | +34% | 22.7% |
| AONAon | $64.4B | 16.7× | 27.9× | 15.8× | 3.7× | +5% | 22.3% |
| AJGArthur J. Gallagher | $68.7B | 44.5× | 33.5× | 19.2× | 4.4× | +26% | 10.0% |
| Peer median | $12.2B | 30.1× | 32.5× | 15.8× | 3.7× | +8% | 14.7% |
Investors who own it
Investors we follow who held Equitable at the end of Jun 30, 2026, from their 13F filings.
- Andreas HalvorsenViking Global Investors0.7% of portfolionew
- Bill NygrenHarris Associates (Oakmark)0.6% of portfolioadded
- Ruane, Cunniff & GoldfarbRuane, Cunniff & Goldfarb (Sequoia Fund)0.0% of portfoliotrimmed
More on Equitable
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to book ratio
- Market cap
- Revenue
- EPS
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .